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that could separate them from the families linked to the chromo-
some 2 NPH locus (named NPH1). This reveals genetic hetero-
geneity also in the purely renal form of NPH. In situ hybridization
of YAC clones isolated with 2 closely linked markers assigned the
NPH1 regions to 2q13. Futhermore, based on haplotype analysis
and specific recombination events, the NPH1 gene has been
placed between D2S293/D2S340 and D2S121, a genetic interval of
about 5 to 7 CM.
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Role of modifier genes in PKD
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The Jackson Laboratoiy, Bar Harbor, Maine, USA
We are studying a new spontaneous mutation, nm1633, that is
an autosomal recessive located on mouse Chromosome 8. Mice
homozygous for the mutated allele are runts during the suckling
period and manifest an unusual facial dysmorphism at the time of
weaning. After weaning, the testes fail to develop normally and
undergo degenerative changes resulting in male sterility. The
kidneys develop a progressive polycystic disease with a pathology
remarkably similar to human autosomal dominant PKD. The
nm1633 mutation occurred on the C57BL/6J inbred strain. On
this genetic background, renal cysts grow at a remarkable constant
rate during the first year of life with the wet weight of the kidneys
doubling eveiy 120 days. Affected animals that survive weaning
appear to die of renal failure at 8 to 12 months of age, and males
live slightly longer than females.
During our initial genetic studies, we used a linkage testing
stock, MeviTy, to determine the chromosomal location of the
nm1633 mutation. Initial difficulties occurred when we were
unable to identify mutant animals in the F2 generation using the
criteria of decreased body size and the presence of a readily
apparent facial dysmorphism at weaning. Gross examination of
the kidneys at 6 to 8 weeks of age also failed to reveal the presence
of cysts. Since renal cysts were readily apparent at this age in
C57BL/6J mice, we concluded that genetic background had a
dramatic affect on the rate of cyst growth. We were eventually able
to map the nml 633 mutation to Chromosome 8 by waiting until
the F2 animals reached 10 months of age when histological
examination of the kidneys confirmed the presence of cystic
disease in approximately 25% of the mice.
Next, we generated an intercross between nm1633-C57BL/6J
and an inbred strain of Mus castaneus, CASTIEi. Because of the
relatively large genetic variation between these two species of
mice, we reasoned it would be easier to fine map the nml 633
mutation on Chromosome 8 in preparation of positional cloning
of the locus. Similarly, scanning the genome for the presence of
modifier genes would also be facilitated with this genetic cross.
Using simple sequence length polymorphisms (SSLPs) and the
(C57BL/6J X CAST/Ei)F1 intercross, nm1633 was fine mapped
on Chromosome 8 and a yeast artificial chromosome (YAC)
contiguous of the region is now almost complete.
Surprisingly, the average rate of cyst growth in the CAST/Ei
intercross was increased rather that decreased as observed with
MeviTy. To map the CASTIEi modifier gene allele responsible for
the increase severity of cystic disease, we scanned the genome of
43 mutant F2 mice using 3 to 6 SSLPs per chromosome. Analysis
of the log wet kidney weight at 6 months of age and the genotype
of all loci examined using MAPMAKER/QTL, identified a mod-
ffier gene on distal mouse Chromosome 19 near Dl9Mitl (LOD
score 3.11) that was responsible for a significant amount (30% to
50%) of the variation of cystic disease observed in the F2 animals.
A second method used to attempt cloning the nm1633 mutation
and possibly identify modifier genes was differential screening of
a mouse kidney cDNA library using radiolabeled cDNA probes
from normal and mutant C57BL/6J mice. Two clones (nm1633A
and nm1633B) were identified that showed three- to fourfold
reduced expression in the mutant kidney. The nm1633B clone
mapped to distal Chromosome 6 near Kap which encodes the
androgen-inducible protein, KAP. DNA sequence analysis con-
firmed that nm1633B was KAP. Interestingly, Calvet and co-
workers have reported reduced expression of KAP in mice with
congenital polycystic kidney disease, cpk, a mutation that maps to
proximal Chromosome 12.
DNA sequence analysis of the nm1633A cDNA also generated
unexpected results. The DNA sequence was strongly related to
the DNA sequence of a human SA protein cDNA clone. The SA
protein was originally identified in the kidney of hypertensive
SHR rats because expression was increased approximately tenfold
over the observed in WKY normotensive rats. For this reason, SA
protein gene is considered a candidate gene affecting severity of
essential hypertension in rats. Our protein database searches for
other amino acid sequences related to both nm1633B and the SA
protein also yielded surprising results. The MACAW protein
sequence alignment program showed that both genes are mem-
bers of a super-gene family of enzymes that bind AlP and
adenylate substrates as part of a two-step mechanism that even-
tually generates AMP and PPi as end products.
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Insertional mutagenesis and PKD
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The molecular charcaterization of genes associated with poly-
cystic kidney disease (PKD) in the mouse represents an important
means of establishing the molecular basis of renal cyst formation
in both mice and humans. We have identified a new recessive
PKD mutation in mice, called TgN737Rpw. Mutant animals in
this line develop bilateral polycystic kidneys and abnormalities
associated with the intrahepatic biliary duct. Gross examination of
mutant kidneys revealed that they were slightly enlarged, pale and
contained numerous cysts with concurrent destruction of the
surrounding parenchyma. The livers were slightly pale with a
prominent reticular pattern. Histologically, the lesions in the
kidneys and livers of TgN737Rpw mutant mice were remarkably
similar to those seen in human ARPKD. The cardinal features of
both the kidney and liver lesion typical of human ARPKD were a
constant finding in the mutant animals. In the kidneys, an initial
nild, multifocal, microscopic dilation of the proximal tubules was
followed rapidly by marked dilation and cyst formation of the
collecting tubules.
The unique feature of the Tg737Rpw mutation is that it arose
ty insertional mutagenesis in one line of our transgenic mice.
tJtilizing transgene sequences as a molecular "tag" for the
integration site in the Tg737Rpw mice, we were able to clone and
characterize the mutant locus and identify a candidate PKD gene
whose expression is directly affected by the mutation in this line.
This was done initially by screening a mutant genomic library with
a probe corresponding to the integrated transgene, which subse-
quently allowed us to clone genomic sequences flanking the
transgene. Unique copy probes derived from the flanking se-
quences were then used to clone the corresponding wild-type
sequences. Comparison of the wild-type and cloned mutant
regions allowed us to derive the structure of the mutant locus. The
transgene integration resulted in the deletion of about 2.5 kb of
host sequences from the integration site, and the co-integration of
an approximately 23 kb genomic fragment with the transgene
sequences.
A gene that spans the transgene integration site was identified,
which we are calling the Tg737 gene. This gene is normally
expressed with a broad tissue distribution, including the adult liver
and kidney, and gives rise predominantly to a 3.2 kb mRNA.
Several cDNA clones representing the Tg737 gene were isolated
and sequenced; one of these, cDNA5, was determined to be 3045
bp in length, and to contain a long open reading frame that
potentially represents the entire peptide encoded by the predom-
inant 3.2 kb mRNA species. Analysis of mutant tissues revealed
that the mutation in this line prevents expression of the 3.2 kb
mRNA.
The protein predicted by cDNA5 is unique and has not been
described previously in GenBank. Analysis of the primary amino
acid sequence and a search with the BLAST network revealed
that the protein contains ten copies of an internally repeated
degenerate 34-amino acid sequence referred to as the tetratri-
copeptide repeat (TPR). The TPR was first described in lower
eukaryotes as a motif associated with several genes involved in cell
cycle control. More recently, TPR-containing proteins in yeast
and Drosophila have been discovered that function in various
cellular processes including protein import, transcription and
neurogenesis. Although it is presently unclear precisely how the
normal expression of the Tg737 gene might prevent PKD in mice,
because TPR genes are associated in some cases with cell cycle
control, we are hypothesizing that this gene may function by
controlling epithelial cell proliferation and/or by regulating the
apoptosis that normally participate in kidney development.
Additionally, utilizing the mouse cDNA as a probe, we have
cloned and sequenced the homologous human gene and have
determined its intron/exon structure. Based on this analysis, we
have determined that the human gene is greater than 100 kb in
size, and contains 26 exons, most of which are less than 100 bp in
length. The human mRNA is smaller than the mouse, due
primarily to a deletion of approximately 293 bases from the 3'
UTR. Comparison of the ORF within the human and mouse
cDNA clones revealed that both contain the same number of TPR
motifs, and both have the potential to encode proteins that are
highly homologous and essentially the same size. The molecular
reagents derived from the analysis of the TgN737Rpw mutant are
allowing us to analyze DNA from human families with PKD in
order to determine whether the Tg737 gene is associated with any
genetic disease conditions in humans that involve the develop-
ment of renal cysts.
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